基于冠脉CT血管成像的血管周围脂肪机器学习放射转录组特征改善心脏风险预测
本研究通过三个研究队列开发并验证了一种人工智能驱动的冠脉周围脂肪放射组学特征(FRP)。研究1将脂肪组织基因表达与CT放射组学特征关联;研究2在101例MACE患者和101例匹配对照中训练随机森林算法,外部验证C统计量为0.77(95%CI: 0.62-0.93);研究3在SCOT-HEART试验1575例参与者中,FRP在传统风险分层基础上显著改善MACE预测(ΔC统计量=0.126,P<0.001)。
要点
- FRP是一种基于CCTA的AI影像生物标志物,可检测冠脉周围脂肪的结构重塑。
- 在SCOT-HEART试验中,FRP在传统风险因素、钙化积分、狭窄及高危斑块特征基础上显著改善MACE预测。
- FRP在急性心肌梗死后6个月保持稳定,可检测FAI未捕捉的持续性PVAT改变。
核心结论
- 基于CCTA的冠脉PVAT放射组学分析可检测与冠状动脉疾病相关的血管周围结构重塑,超越炎症范畴。
- AI驱动的影像生物标志物FRP在当前最先进的风险预测基础上显著改善心脏风险预测。
研究设计与样本
- 研究1:167例接受心脏手术患者的脂肪组织活检,分析基因表达与CT放射组学特征的关联。
- 研究2:101例CCTA后5年内发生MACE的患者与101例匹配对照,分析1391个冠脉PVAT放射组学特征,训练并验证随机森林算法(FRP)。
- 研究3:SCOT-HEART试验中1575例连续合格参与者,测试FRP对MACE预测的改善。
- 研究3补充:44例急性心肌梗死患者与44例匹配对照,比较FRP与FAI在事件后6个月的变化。
主要发现
- 脂肪组织小波变换平均衰减(FAI)是描述组织炎症(TNFA表达)最敏感的放射组学特征。
- 放射组学纹理特征与脂肪组织纤维化(COL1A1表达)和血管性(CD31表达)相关。
- FRP区分MACE病例与对照的外部验证C统计量为0.77(95%CI: 0.62-0.93)。
- 在SCOT-HEART试验中,FRP在包含风险因素、冠脉钙化评分、冠脉狭窄和CCTA高危斑块特征的传统风险分层基础上显著改善MACE预测(ΔC统计量=0.126,P<0.001)。
- FRP在急性心肌梗死患者中显著高于匹配对照,但在事件后6个月保持不变,而FAI无此表现。
关键数值与推荐
- FRP外部验证C统计量:0.77(95%CI: 0.62-0.93)。
- SCOT-HEART试验中FRP改善MACE预测的ΔC统计量=0.126,P<0.001。
- 研究2分析1391个冠脉PVAT放射组学特征。
- 研究1纳入167例心脏手术患者;研究3纳入1575例SCOT-HEART参与者;急性心肌梗死亚组44例对44例匹配对照。
临床怎么用
- 在CCTA检查中可提取冠脉PVAT放射组学特征(FRP),辅助识别传统风险分层未充分捕捉的高危患者。
- FRP可检测持续性PVAT结构重塑,可能补充FAI对炎症的动态评估。
- FRP作为AI影像生物标志物,有望整合进CCTA报告流程以改善心脏风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary inflammation induces dynamic changes in the balance between water and lipid content in perivascular adipose tissue (PVAT), as captured by perivascular Fat Attenuation Index (FAI) in standard coronary CT angiography (CCTA). However, inflammation is not the only process involved in atherogenesis and we hypothesized that additional radiomic signatures of adverse fibrotic and microvascular PVAT remodelling, may further improve cardiac risk prediction. METHODS AND RESULTS: We present a new artificial intelligence-powered method to predict cardiac risk by analysing the radiomic profile of coronary PVAT, developed and validated in patient cohorts acquired in three different studies. In Study 1, adipose tissue biopsies were obtained from 167 patients undergoing cardiac surgery, and the expression of genes representing inflammation, fibrosis and vascularity was linked with the radiomic features extracted from tissue CT images. Adipose tissue wavelet-transformed mean attenuation (captured by FAI) was the most sensitive radiomic feature in describing tissue inflammation (TNFA expression), while features of radiomic texture were related to adipose tissue fibrosis (COL1A1 expression) and vascularity (CD31 expression). In Study 2, we analysed 1391 coronary PVAT radiomic features in 101 patients who experienced major adverse cardiac events (MACE) within 5 years of having a CCTA and 101 matched controls, training and validating a machine learning (random forest) algorithm (fat radiomic profile, FRP) to discriminate cases from controls (C-statistic 0.77 [95%CI: 0.62-0.93] in the external validation set). The coronary FRP signature was then tested in 1575 consecutive eligible participants in the SCOT-HEART trial, where it significantly improved MACE prediction beyond traditional risk stratification that included risk factors, coronary calcium score, coronary stenosis, and high-risk plaque features on CCTA (Δ[C-statistic] = 0.126, P < 0.001). In Study 3, FRP was significantly higher in 44 patients presenting with acute myocardial infarction compared with 44 matched controls, but unlike FAI, remained unchanged 6 months after the index event, confirming that FRP detects persistent PVAT changes not captured by FAI. CONCLUSION: The CCTA-based radiomic profiling of coronary artery PVAT detects perivascular structural remodelling associated with coronary artery disease, beyond inflammation. A new artificial intelligence (AI)-powered imaging biomarker (FRP) leads to a striking improvement of cardiac risk prediction over and above the current state-of-the-art.
引用
- Oikonomou EK, Williams MC, Kotanidis CP, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019. PMID: 31504423. doi:10.1093/eurheartj/ehz592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。